Title:
【発明の名称】回腸胆汁酸輸送阻害剤化合物を含む回腸投与のための経口製剤
Document Type and Number:
Japanese Patent JP2002542208
Kind Code:
A
Abstract:
An oral pharmaceutical formulation comprising an inhibitor compound of the ileal bile acid transport (IBAT inhibitor compound) and a therapeutically acceptable carrier characterised in that the formulation is designed to deliver the IBAT inhibitor compound in the ileum. The IBAT inhibitor compound can also be administered in combination with a bile acid binder to alleviate possible side effects of therapy with IBAT inhibitor compound, such as for instance diarrhoea. The bile acid binder may be formulated for colon release.
Inventors:
Abraham Husson, Bertil
Lindkwist, Anne-Margret
Ungel, Anna-Lena
Lindkwist, Anne-Margret
Ungel, Anna-Lena
Application Number:
JP2000611946A
Publication Date:
December 10, 2002
Filing Date:
April 19, 2000
Export Citation:
Assignee:
AstraZeneca Activrag
International Classes:
A61K9/20; A61K9/50; A61K31/00; A61K47/30; A61K31/554; A61K45/00; A61K45/06; A61P3/06; (IPC1-7): A61K45/00; A61K47/30; A61P3/06
Attorney, Agent or Firm:
Kazuo Shamoto (5 outside)